Divi's Laboratories Limited — Board Meeting, 03-02-2025: Outcome of Board Meeting

The Board of Directors approved the financial results for the quarter and nine months ended December 31, 2024. The consolidated total income reached ₹2401 crores, up from ₹1950 crores year-on-year, with a profit before tax (PBT) of ₹726 crores compared to ₹489 crores previously. The profit after tax (PAT) was ₹589 crores, up from ₹358 crores. Additionally, the board re-appointed Dr. Kiran S. Divi as Whole-time Director and CEO for a period of five years starting April 1, 2025, pending member approval via postal ballot. The company also reported a forex gain of ₹10 crores for the quarter.